Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting January 12th, 2022.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Abbott Labs
Symbol: ABT
Recent ABT Stock Price: $113.85
Average Analyst Price Target: $119.85 (5.27%)
ABT Market Cap: $195.86B
Expected Ex-Dividend Date for ABT stock: Jan 12 2023
Expected Payment Date for ABT stock: Feb 15 2023
Expected Dividend & Yield for ABT stock: 1.67%
Recent Analyst Action: Cecilia Furlong, analyst at Morgan Stanley, reiterates coverage on Abbott Labs (ABT) stock in the Healthcare sector with a Buy rating and a price target of $ 133 (4 days ago).
TipRanks.com also reports that Abbott Labs stock currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $119.85 . The target pricing ranges from a high forecast of $140.00 down to a low forecast of $105.00. Abbott Labs (ABT)’s last closing stock price was $113.85 which would put the average price target at 5.27% upside.Here are 3rd party ratings for ABT stock:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Bottom 40% (149 out of 250)
--------------------------------------------------------------------------
AbbVie
Symbol: ABBV
Recent ABBV Stock Price: $159.64
Average Analyst Price Target: $159.29 (-0.22%)
ABBV Market Cap: $294.54B
Expected Ex-Dividend Date for ABBV stock: Jan 12 2023
Expected Payment Date for ABBV stock: Feb 15 2023
Expected Dividend & Yield for ABBV stock: 3.39%
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on AbbVie (ABBV) stock in the Healthcare sector with a Buy rating and a price target of $ 180 (5 days ago).
TipRanks.com also reports that AbbVie stock currently has 15 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $159.29 . The target pricing ranges from a high forecast of $190.00 down to a low forecast of $135.00. AbbVie (ABBV)’s last closing stock price was $159.64 which would put the average price target at -0.22% upside.Here are 3rd party ratings for ABBV stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 34% (84 out of 250)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.